037sek
-4,3 %
Date:2026-04-02Time:13:30:00Latest report:Q4-2025List:Small CapTicker:NICA
Market Cap:46 msekEnterprise Value:64 msekNet Sales:21,1 msekEarnings:-51,3 msekEmployees:0ISIN:SE0005454873

Ratios

10-year key figure history for Nanologica turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanologica with index and moving average MA50 and MA200.

Stockprice:0,37
MA50:0,41
MA200:0,97
Price/MA200:-61,6 %
RSI (14):45,0
Price/MA50:-9,6 %

Description

Nanologica is a life science tools company that develops, manufactures and sells advanced input products to pharmaceutical companies. Nanologica's silica-based products are specifically designed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Nanologica operates in a global niche market for drugs for the treatment of diabetes and obesity. Nanologica was founded in 2004 and is headquartered in Södertälje.

Biotechnology